Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology

Pediatric Rheumatology Collaborative Study Group – over four decades of pivotal clinical drug research in pediatric rheumatology

Abstract Importance Specialized research networks are essential to achieve drug approvals for rare pediatric diseases. Such networks help realize the potential of global legislation enacted upon the recognition that most children are treated with drugs whose most beneficial dose and regimen have not...

Full description

Bibliographic Details
Main Authors: Hermine I. Brunner, Lisa G. Rider, Daniel J. Kingsbury, Dominic Co, Rayfel Schneider, Ellen Goldmuntz, Karen B. Onel, Edward H. Giannini, Daniel J. Lovell, for the PRCSG Advisory Council
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Clinical trials
JIA
PRCSG
Drug approvals
Pediatrics
Networks
Online Access:http://link.springer.com/article/10.1186/s12969-018-0261-x

Internet

http://link.springer.com/article/10.1186/s12969-018-0261-x

Similar Items